Mefenaminsaeure Brand names, Mefenaminsaeure Analogs
Mefenaminsaeure Brand Names Mixture
Mefenaminsaeure fda sheet
Mefenaminsaeure msds (material safety sheet)
Mefenaminsaeure Synthesis Reference
No information avaliable
Mefenaminsaeure Molecular Weight
Mefenaminsaeure Melting Point
Mefenaminsaeure H2O Solubility
Mefenaminsaeure Dosage Forms
Bolus; Capsule; Capsule (enteric-coated); Drops; Liquid; Lotion; Powder; Powder for solution; Shampoo; Soap bar; Solution; Stick; Syrup; Tablet; Tablet (extended-release)
For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.
Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.
Mefenamic acid is rapidly absorbed after oral administration.
Mefenaminsaeure side effects and Toxicity
Oral, rat LD50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.
Mefenaminsaeure Patient Information
Mefenaminsaeure Organisms Affected
Humans and other mammals